Although a statistically significant negative correlation between survival and GLI1 expression has been shown in breast [29], esophageal [30], colorectal [31], and bladder cancers [32], this is the first study to demonstrate a clinical impact of GLI1 on patient survival in lung adenocarcinoma. Here, GLI1 is linked to urinary bladder carcinoma.